Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
  • USA
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Biotechnology
  • Health Tech
  • AI
About
ALS Investment Fund backs biotech firms targeting neurodegenerative diseases like ALS, Alzheimer’s, and Parkinson’s. The fund supports platform-based approaches and experienced scientific leadership.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

They invest in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus in ALS.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Focused on early-stage investments in technology-driven sectors, with a strong emphasis on fintech and healthtech. Backed 50+ startups across North America and Europe, showcasing a commitment to identifying high-potential opportunities. Known for a hands-on investment style that fosters operational excellence and rapid market entry. Recognized for achieving multiple successful exits, demonstrating a keen eye for growth and value creation in niche markets.

ALS Investment Fund Contacts Information

Primary contact

Secondary contact

Team

Craig Boyce

Felix Von Coerper

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp